TY - JOUR T1 - Fetal supraventricular tachycardia diagnosed and treated at twenty-four weeks of gestation and after birth: a case report. AU - Romeo,Emanuele, AU - D'Alto,Michele, AU - Russo,Maria Giovanna, AU - Sarubbi,Berardo, AU - Cardaropoli,Dominga, AU - Paladini,Dario, AU - Pacileo,Giuseppe, AU - Annunziata,Annalisa, AU - Calabrò,Raffaele, PY - 2005/1/1/pubmed PY - 2005/4/9/medline PY - 2005/1/1/entrez SP - 777 EP - 80 JF - Italian heart journal : official journal of the Italian Federation of Cardiology JO - Ital Heart J VL - 5 IS - 10 N2 - Supraventricular tachycardia is the most common clinically significant fetal tachycardia. The diagnosis is usually made at routine sonographic workup during the second-third trimester of pregnancy. Treatment goals are cardioversion to sinus rhythm and reversal of cardiac dysfunction. We describe a case of fetal supraventricular tachycardia diagnosed at 24 weeks of gestation. The first-line treatment was oral maternal digoxin and sotalol. This therapy was not sufficient for complete control of the tachycardia. Hence, second-line treatment with digoxin and flecainide was started and successfully achieved conversion to sinus rhythm. No adverse maternal side effects were noted during the 14 weeks of therapy. A normal male infant was delivered at elective cesarean section performed for obstetric indications at 38 weeks of gestation. A persistent junctional reciprocating tachycardia with a ventriculo-atrial/atrioventricular ratio > 1 was diagnosed following delivery at transesophageal electrophysiological study. At the age of 8 months the child is on therapy with sotalol (4 mg/kg/day) and flecainide (3 mg/kg/day) and is in good clinical conditions. SN - 1129-471X UR - https://www.unboundmedicine.com/medline/citation/15626276/Fetal_supraventricular_tachycardia_diagnosed_and_treated_at_twenty_four_weeks_of_gestation_and_after_birth:_a_case_report_ DB - PRIME DP - Unbound Medicine ER -